You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

FEMSTAT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Femstat, and when can generic versions of Femstat launch?

Femstat is a drug marketed by Roche Palo and Bayer and is included in three NDAs.

The generic ingredient in FEMSTAT is butoconazole nitrate. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the butoconazole nitrate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FEMSTAT?
  • What are the global sales for FEMSTAT?
  • What is Average Wholesale Price for FEMSTAT?
Summary for FEMSTAT
US Patents:0
Applicants:2
NDAs:3
Raw Ingredient (Bulk) Api Vendors: 105
Patent Applications: 1,009
DailyMed Link:FEMSTAT at DailyMed
Drug patent expirations by year for FEMSTAT

US Patents and Regulatory Information for FEMSTAT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche Palo FEMSTAT butoconazole nitrate CREAM;VAGINAL 019215-001 Nov 25, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Roche Palo FEMSTAT butoconazole nitrate SUPPOSITORY;VAGINAL 019359-001 Nov 25, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayer FEMSTAT 3 butoconazole nitrate CREAM;VAGINAL 020421-001 Dec 21, 1995 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for FEMSTAT

See the table below for patents covering FEMSTAT around the world.

Country Patent Number Title Estimated Expiration
Germany 2800755 ⤷  Sign Up
Netherlands 184160 ⤷  Sign Up
Sweden 7800111 ⤷  Sign Up
Norway 760783 ⤷  Sign Up
Netherlands 7608297 ⤷  Sign Up
Switzerland 623040 Process for the preparation of substituted N-alkylimidazoles ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.